Fig. 3: Impact of consortium administration on PD pathophysiology in a D. melanogaster model. | npj Biofilms and Microbiomes

Fig. 3: Impact of consortium administration on PD pathophysiology in a D. melanogaster model.

From: A rationally designed microbial consortium modulates neurodegeneration in a Drosophila melanogaster model of Parkinson’s disease

Fig. 3

A Climbing assay at 10 days. B Climbing assay at 25 days. C Dopaminergic neurons positive for Tyrosine Hydroxylase enzyme, labeled with an antibody against the enzyme. The picture corresponds to a control fly fed with the consortium. D Analysis of dopaminergic neurons in the each group at 25 days. Statistical analysis was performed with two-way ANOVA followed by Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001).

Back to article page